A major concern regarding ventralis intermedius nucleus deep brain stimulation for essential tremor has been the loss of surgical efficacy over time in a minority of patients. Some experts have ascribed the worsening tremor to tolerance, while other evidence has suggested that disease progression may play a role. Suboptimal lead placement has also been reported to be a factor in worsening tremor following deep-brain stimulation; however, most authors consider this phenomenon to manifest within a few months of the actual surgery. We aimed to dissect the tolerance versus disease progression issue by analysing preoperative versus long-term post-surgical Fahn-Tolosa-Marin Tremor Rating Scale scores both on and off stimulation among 28 patients who underwent ventralis intermedius nucleus deep brain stimulation and 21 age-matched controls. Of the 28 patients in the treatment arm of the cohort, seven (25%) demonstrated evidence of tremor progression, and had a 34% increase in the tremor score off stimulation at the 36 month follow-up compared with a 32% increase among controls (P = 0.67). In one of the seven patients there was evidence of suboptimal lead placement given the lateral position of the lead, and the motor side effects during threshold testing. This patient demonstrated a loss of stimulation benefit between 24 and 36 months, which may have been more indicative of tolerance. The other six subjects (86%) maintained stimulation benefit throughout the follow-up period, despite worsening tremor off stimulation (at a comparable rate to that of controls), making disease progression the most likely explanation. The data suggest that deep brain stimulation tolerance may be over-reported in the literature, and that a tolerance versus disease progression work-up should include: examining the trend in off stimulation scores, accounting for image based lead locations, and during programming sessions checking for thresholds which may elicit clinical benefits and side effects.
Introduction
Essential tremor is a common movement disorder that can result in significant functional disability especially in severe cases (Koller et al., 2001; Zhang et al., 2010) . Essential tremor is usually slowly progressive with a variable clinical course and variable response to medical treatment (Louis et al., 2000; Jankovic, 2002; Putzke et al., 2006; Louis et al., 2009; Sulica and Louis, 2010) .
There are many pharmacological treatments for essential tremor, however, few effectively control moderate to severe tremor, especially over time (Koller et al., 2001; Zhang et al., 2010) . ventralis intermedius nucleus deep brain stimulation (DBS) has been proven to be an effective surgical treatment for select patients who are refractory to pharmacological treatment (Alesch et al., 1995; Lee and Kondziolka, 2005) .
A main concern regarding ventralis intermedius nucleus-DBS for essential tremor has been the loss of surgical efficacy over time in a minority of patients. Some experts ascribed the worsening tremor to tolerance (the brain's loss of responsiveness to the ventralis intermedius nucleus-DBS) (Benabid et al., 1996; Ruiz et al., 2001; Kumar et al., 2003; Pilitsis et al., 2008; Zhang et al., 2010) . However, there is evidence to suggest that disease progression may actually be primarily responsible for the gradual worsening of tremor in ventralis intermedius nucleus-DBS patients (Sydow et al., 2003; Pilitsis et al., 2008) . Suboptimal lead placement has also been reported to be a factor in worsening tremor post-DBS; however, most authors consider this phenomenon to manifest before 6 months of therapy (Pilitsis et al., 2008) . The gradual increase in voltage of the DBS device has been reported as a potential sign of ventralis intermedius nucleus-DBS tolerance, but there has never been a careful consideration of disease progression as a contributing factor (Benabid et al., 1996; Ruiz et al., 2001; Kumar et al., 2003; Pilitsis et al., 2008; Zhang et al., 2010) . Some authors have addressed this issue by focusing on patients that experienced a decrease in difference between on and off stimulation tremor scores. Still, this issue may be studied among patients with worsening of underlying tremor, as measured by tremor score off stimulation. Some subjects with worsening underlying tremor will demonstrate consistent response to stimulation, while others fail to do so. This may represent an alternative approach to addressing tolerance versus disease progression.
Essential tremor is a heterogeneous disease with a highly variable rate of disease progression (Louis et al., 2000; Jankovic, 2002) . The disease progression has been recently thought to be due to neurodegeneration (Louis et al., 2007; Axelrad et al., 2008; Louis, 2009 ) and progression has not been traditionally factored into long-term efficacy assessments of ventralis intermedius nucleus-DBS.
In this retrospective study, we sought to extract and to utilize long-term data from the University of Florida INFORM database. We aimed to dissect the tolerance versus disease progression issue by analysing preoperative tremor scores versus post-operative long-term (24-36 months) DBS tremor scores both on and off stimulation. We hypothesized that patients with essential tremor with or without ventralis intermedius nucleus-DBS would demonstrate a similar and slow clinical deterioration over time. We further reasoned that this deterioration would be expected in natural disease progression and that the baseline scores over time would worsen, but stimulation benefit would be persistent. We also hypothesized that if tolerance was an issue, the deterioration of stimulation benefit over time would occur at a faster and different slope than that seen in non-DBS essential tremor disease progression.
Materials and methods

Study population
An institutional review board approved University of Florida-INFORM database search of all patients with essential tremor treated with DBS surgery between January 2002 and April 2010 was performed. Inclusion was dependent upon the availability of demographic features, baseline Fahn-Tolosa-Marin Tremor Rating Scale scores, and the presence of clinical follow-up of at least 36 months.
General characteristics of the cohort were noted. Age, sex, duration of essential tremor symptoms, DBS target coordinates, preoperative history of psychiatric disorders and medications at each visit were recorded. MOS (Medical Outcome Study) 36-item short-form health quality of life survey (SF-36), Patient Global Impression Scale (PGIS) and Clinical Global Impression Scale (CGIS) were also noted. Tremor rating scale total and subscores were noted at baseline examination (pre-DBS) as well as at follow-up examinations at 6, 12, 24 and 36 months. The tremor rating scale motor score includes Fahn-TolosaMarin tremor rating scale questions 1-14 (parts A and B), addressing tremor severity, location and function in drawing and pouring. Tremor rating scale activities of daily living score includes questions 15-21. At all follow-up examinations, tremor rating scale scores were recorded both on and off stimulation (off stimulation condition always followed the on condition, and was after an off period of 30 min-patients and examiners not blinded). At each examination, a single assessor assigned all tremor rating scale scores. The same assessor did not, however, reassess every patient at each follow-up examination. All examiners at the University of Florida Movement Disorder Centre were trained by a movement disorders specialist. The Fahn-TolosaMarin tremor rating scale has been demonstrated to maintain good interrater reliability with training (Stacey et al., 2007) . Laterality of lead placement was recorded for all subjects. Comparisons were performed between baseline characteristics of unilateral and bilateral subjects, and all outcome analyses were performed separately for unilateral and bilateral subjects.
A total of 69 patients with essential tremor received DBS surgery at the University of Florida Centre for Movement Disorders and Neurorestoration between January 2002 and April 2010. Ten subjects were excluded from analysis because they received prior DBS surgery at an outside facility. An additional four subjects were excluded because the stimulator was revised in a second procedure. Twenty-four subjects were excluded because they did not have an examination performed between 24 and 36 months (13 subjects lost to follow-up and 11 subjects were operated on too recently). One subject was excluded because the DBS target was changed to subthalamic nucleus, and two subjects were excluded because the DBS batteries were not placed following lead insertion (Fig. 1) . Twenty-one age-matched controls with essential tremor but no DBS were drawn from the institutional review board approved University of Florida-INFORM database. Cohort inclusion criteria were applied during the control selection process, and all demographic and clinical characteristics were recorded as described above including the same follow-up schedule as all DBS subjects.
For the purposes of the current study, we defined disease progression to be an increase in tremor rating scale motor score off stimulation between 6 and 36 months post-DBS, with maintained on-off benefit between the same intervals. We also defined DBS tolerance as a decrease in stimulation benefit (decrease in on-off difference) between 6 and 36 months. Six patients (21% of cohort) demonstrated a pattern of disease progression, and one patient (4%) demonstrated a pattern of tolerance. In all cases of suspected disease progression and tolerance, suboptimal lead placement was considered a possible underpinning, and imaging with x, y, z target coordinates, the operative report and clinical thresholds for benefits and side effects during programming were reviewed.
Statistical analysis
The primary outcome measure was tremor rating scale motor score off stimulation and at the follow-up examination at 36 months. In order to assess progression of tremor, the Wilcoxon signed-rank test was employed to compare baseline tremor rating scale scores to follow-up tremor rating scale scores off stimulation. Secondarily, other follow-up tremor rating scale scores off stimulation (6, 12 and 24 months) were also compared with the baseline score. Additionally, the Kruskal-Wallis test was used to compare performance at all follow-up examinations to assess potential change in tremor within the follow-up period. All analyses were performed separately for unilateral and bilateral patients.
In order to confirm the efficacy of DBS stimulation, tremor rating scale scores were recorded while on and off stimulation at each follow-up examination. The Wilcoxon signed-rank test was employed to compare on and off scores in a paired fashion at each follow-up examination. In order to explore the possible diminishing benefit of stimulation over time, the Kruskal-Wallis test was used to compare benefit of stimulation (on-off difference) at each examination date throughout the follow-up period. Again, all analyses were performed separately for unilateral and bilateral patients.
Medications used for tremor control were compared between unilateral and bilateral DBS patients using a chi-squared test. Pre-DBS medications were compared with post-DBS medications in a paired fashion with the Wilcoxon signed-rank test.
For secondary analysis, the cohort was categorized based on baseline tremor severity (tremor rating scale motor scores: mild 535; moderate 35-45; severe 445). Progression of tremor was explored across tremor severity subgroups using the Kruskal-Wallis test.
The phenomenon of secondary progression of tremor was also assessed, as defined as an increase in tremor rating scale motor score off stimulation between 6 and 36 months post-DBS. Surgical details, including target coordinates, lead angles, complications and intraoperative responses were all abstracted from operative reports. For these subjects, on and off stimulation tremor scores and stimulation parameters, including thresholds, were explored.
All statistical analyses were performed with Stata/SE 10.0 (StataCorp).
Results
Twenty-eight subjects met inclusion criteria and remained in the final cohort. Excluded patients were similar to subjects in the final cohort with respect to all demographic features, baseline tremor severity, and surgical characteristics, and excluded subjects experienced fewer years of symptoms as compared with those included in the final cohort. The DBS arm of the cohort was similar to controls with respect to demographic features, and controls had less severe baseline tremor and fewer years of tremor symptoms (Table 1) .
Of the 28 subjects in the final cohort, 19 received placement of DBS leads unilaterally, while nine subjects received bilateral leads. Those who received unilateral surgery did not differ from those who received bilateral surgery, with respect to demographic features, and baseline clinical performance (Table 2) .
Medications (including dose) utilized to control tremor before and after DBS surgery were recorded for all patients in the cohort, and medication usage was found to be similar between patients receiving unilateral and bilateral stimulation. Medication usage before and after DBS was compared (Table 3) , and tremor control medications, in particular primidone, were used more frequently prior to than after DBS surgery. Follow-up tremor rating scale scores (both motor score and activities of daily living score) were then analysed in the absence of stimulation (off stimulation condition) in order to assess the progression of the tremor. Improvement of tremor was noted among the unilateral group at every follow-up time point when compared with the baseline score. In the bilateral group, no change was noted between tremor at baseline and follow-up time points in the absence of stimulation. In the control group, follow-up tremor scores were initially comparable to baseline, but tremor worsened at 36 months (P = 0.015). Nevertheless, all patients in the treatment group demonstrated improvement with respect to activities of daily living compared with baseline performance (Table 4) . Tremor rating scale motor scores off stimulation remained unchanged throughout the follow-up period for both unilateral and bilateral patients (Kruskal-Wallis test: P = 0.97 for unilateral; P = 0.95 for bilateral; P = 0.31 for controls).
In order to address the efficacy of DBS stimulation, tremor rating scale scores were recorded while both on and off stimulation at each follow-up examination interval. Stimulation improved the tremor rating scale motor score at all visits, and this was observed for both unilateral and bilateral stimulation (Table 5) . Furthermore, the benefit achieved through stimulation was consistent throughout the follow-up period for both the unilateral and bilateral patients (Kruskal-Wallis test: P = 0.77 for unilateral; P = 0.43 for bilateral).
Subjects in the treatment arm were secondarily categorized on baseline tremor severity (tremor rating scale motor scores: mild 535; moderate 35-45; severe 445). The three subgroups were indistinguishable with respect to demographic features and baseline characteristics. At 6 months, all subgroups achieved improvement of tremor (absolute score improvement and percentage score improvement), and there were no differences between the three groups. However, at 36 months, the tremor improvement varied across the three subgroups, as identified by Kruskal-Wallis test (P = 0.032). Subjects with a mild baseline tremor worsened by 19% at 36 months (in comparison to baseline off stimulation scores), while those with moderate and severe baseline tremors demonstrated improvement in tremor of 24% and 29%, respectively. While this difference was noted with respect to progression of tremor in the absence of stimulation, all three groups achieved equivalent benefit from stimulation at the initial and long-term follow-up (Table 6 ).
This project sought to specifically explore subjects with worsening of tremor in the off state and to try to define either disease progression or tolerance. Seven subjects were isolated from the cohort with evidence of secondary progression of tremor, as defined as an increase in the off tremor rating scale motor score between 6 and 36 months post-DBS. All seven subjects had a well-documented motor response to stimulation in the operative suite. One intra-operative complication was noted, a small clinically asymptomatic intraventricular haemorrhage in a single patient. Thresholds for side effects and benefits were abstracted from clinic notes (1 month postoperatively), and found to be reasonable and there was expected generation of paraesthesia of the contralateral hand in all but one patient. The one outlying patient experienced pulling of the contralateral tongue and face, and not paraesthesia as a side effect. The surgical target coordinates and lead angles were consistent for all subjects, with the exception of the one subject with abnormal motor and not sensory programming thresholds and in this patient, the lead was observed to be placed slightly more lateral than the rest of the group (lateral coordinate = 16.7 mm). The other six patients had a lateral lead coordinate that was indistinguishable from the remaining cohort (13.2 versus 13.8 mm, P = 0.40). The clinical course of all seven subjects of interest was free of device complications, and there was only one internal pulse generator replacement due to battery drain. For these subjects, progression of tremor and differences between tremor scores on and off stimulation were carefully explored. While tremor rating scale motor scores off stimulation increased over the follow-up period, benefit of stimulation was always present in all but one subject ( Fig. 2A) . The one individual who experienced loss of stimulation benefit was also the subject in whom there were concerns about lead placement because of motor side effects during threshold testing, and the lateral lead location (Fig. 2B ).
Control subjects demonstrated progression of tremor in a similar pattern to the above seven subjects. Controls had a 32% increase in tremor score, and the subjects with worsening post-DBS experienced a similar 34% increase in tremor score (P = 0.67). DBS subjects without worsening of tremor noted an improvement of symptoms off stimulation over the follow-up period of 22% (Fig. 3) .
Discussion
The underlying reasons for tremor worsening following ventralis intermedius nucleus-DBS have not clearly been defined in the literature. Studies have attributed long-term stimulation failure to DBS tolerance, natural disease progression or a combination (Benabid et al., 1996; Ruiz et al., 2001; Kumar et al., 2003; Sydow et al., 2003; Pilitsis et al., 2008; Zhang et al., 2010) . Identifying the predominant underlying aetiology for long-term essential tremor progression post-ventralis intermedius nucleus-DBS has been further complicated by several confounding variables. The gradual loss of the microthalamotomy effect (Benabid et al., 1991; Sydow et al., 2003) , the potential for increased impedance in brain tissue over time (Benabid et al., 1991) , and the long-term stimulation-induced effects (Pilitsis et al., 2008) may all potentially contribute to the post-DBS worsening of essential tremor. In addition, suboptimal DBS placement is thought to be responsible for an unsustained benefit particularly when 56 months (Pilitsis et al., 2008) . Additionally, a better understanding of disease progression in essential tremor may prove critical in understanding the efficacy of any future therapeutic intervention.
The current study utilized the University of Florida-INFORM database to explore the issue of disease progression versus tolerance. Specifically, this study directed attention to seven patients (25%) within the DBS cohort that demonstrated worsening of their off DBS scores over time. Six (86%) of these seven patients also demonstrated a sustained benefit of stimulation and this pattern would be suggestive of potential disease progression rather than tolerance (Fig. 2A) . The argument for tolerance could only be made for one (14%) of the seven patients, who interestingly experienced a sharp decline in benefit after 24 months; however, this patient also had a slightly suboptimal lead placement as revealed by both clinical thresholds and by lead location (Fig. 2B) . Usually suboptimal lead location is more typically responsible for loss of stimulation benefit within a few months after the surgery (Pilitsis et al., 2008; Zhang et al., 2010) ; however, in this case it is conceivable that it could have played a role in progression even at 24 months post-implantation. Comparison between progression of the off DBS scores and control (non-DBS) scores further confirmed that the rate of tremor progression was quite consistent with natural disease progression even when compared to a less severe control group (Fig. 3) . This rate of tremor progression is consistent with previous longitudinal studies of essential tremor disease progression (Putzke et al., 2006; Louis et al., 2011) . The literature may thus overemphasize the role of tolerance in such cases. All of the available literature addressing the issue of tolerance versus disease progression has focused on cohorts that experienced a loss of stimulation benefit years following a DBS surgery (Pilitsis et al., 2008) . In our study, we parcelated out the on/off DBS states in addition to looking at long-term outcomes. We would argue that the question of tolerance versus disease progression can be more easily demonstrated in a longitudinal cohort that includes subjects with worsening of tremor off stimulation. While both scores (on and off) may increase throughout the follow-up period, a sustained benefit of stimulation with a coincident worsening in the off stimulation condition make disease progression and not tolerance a very attractive explanation. Of note, these patients fared well clinically regardless of worsening underlying tremor because of their maintained stimulation benefit. In contrast, a loss of stimulation benefit over time (the on state only) may be more indicative of tolerance. The data from our cohort is bolstered by the long-term follow-up, and by the availability of the off DBS condition scores. It is, however, hampered by washout effects (only 30 min off stimulation), and it also lacks 1 month postoperative off scores (to account for the microlesion effects). It has been demonstrated in Parkinson's disease that tremor re-emergence occurs within minutes of turning off stimulation, and reaches a maximal amplitude within minutes. The tremor seems to reach a plateau within 30 min, but there is a paucity of data addressing re-emergence of tremor in essential tremor (Lopiano et al., 2003; Temperli et al., 2003; Blahak et al., 2009) . In the absence of a thorough study of the temporal re-emergence of essential tremor, the washout period employed in the current study must be interpreted cautiously. A rebound effect has been reported, where action tremor can be observed to be worse after turning the stimulator off, but this was observed more often in Parkinson's disease than essential tremor, reported in only $10% of patients with essential tremor (Benabid et al., 1996; Hariz et al., 1999) . In reporting a rebound effect, one must be careful as rebound could also possibly represent underlying disease progression. In the current study, if a rebound effect were possibly present, it would inappropriately amplify both the measured benefit of stimulation, as well as the underlying tremor progression. It is important to keep in mind however that the majority of the cohort demonstrated improvement when off stimulation, in comparison to baseline preoperative exams. Additionally, when examining essential tremor progression, it must be considered that essential tremor subtypes may be responsible for statistical outliers, and that there may have been selection biases in including only the worst cases in the DBS group.
Medications used to control tremor may confound results, but there were no differences noted in medication usage between the patients receiving unilateral and bilateral stimulation. As expected, there was a decrease in medication usage, particularly primidone, after DBS surgery in both the unilateral and bilateral groups as demonstrated in Table 3 .
Stimulation holidays may provide insight into the role of disease progression versus DBS tolerance. Some studies have reported that stimulation holidays temporarily restored DBS efficacy, suggesting that DBS tolerance was the underlying mechanism (Benabid et al., 1996; Ruiz et al., 2001) , however one study reported no effect of holidays (Pilitsis et al., 2008) . Our study did not include long-term stimulation breaks. Another unique opportunity to explore disease progression may be found in patients that receive an implanted lead but not a battery placement. Many authors assume the microthalotomy effect is responsible for much of the acute benefit of DBS, and this may introduce further uncertainty in the assessment of disease progression. Two patients in our cohort were excluded as they failed to receive battery placement following lead implantation. These two patients represent a potential future population that could help elucidate the microthalotomy (implantation) effect, and in future studies, such patients may facilitate a more effective study of disease progression.
Analysis of follow-up tremor rating scale motor scores off stimulation revealed an interesting benefit among those receiving unilateral lead placement. This benefit could represent a microlesional effect in unilateral predominant tremor. This benefit off stimulation was not observed in the group that received bilateral lead placement. Interestingly, within both the unilateral and bilateral DBS groups, follow-up on stimulation examinations were indistinguishable from one another. This may reflect the slow and variable nature of disease progression (Louis et al., 2000; Jankovic, 2002; Putzke et al., 2006; Spanaki and Plaitakis, 2009) , the significance of which escapes the power of the current study. This may represent a difference in disease progression, though prior studies have observed that more unilateral disease progresses more rapidly than bilateral disease (Louis et al., 2000; Putzke et al., 2006) , but response to DBS has not been specifically addressed in these types of patients. This difference between unilateral and bilateral implantation effect may suggest symptoms of bilateral disease that evade the microthalamotomy effect and will require further investigation. Still, the efficacy of stimulation, as reported in Table 5 , appeared consistent throughout time for the vast majority of subjects.
Subgroup analysis based on baseline tremor severity suggested that all groups experienced initial tremor improvement after DBS surgery, as measured by tremor rating scale motor score off stimulation at 6 months, but this change did not hold at long-term follow-up. At 36 months, subjects with a mild baseline tremor (tremor rating scale motor score 535) demonstrated worsening of tremor in the absence of stimulation, while subjects with moderate or severe baseline tremors continued to demonstrate improvement of tremor at 36 months (relative to baseline). This may suggest that the microlesion effect is more efficacious or noticeable among patients with more severe disease (e.g. a floor effect). Controls had less severe disease, and could not be categorized in this manner, so a reliable comparison of disease progression unfortunately could not be made for this subgroup analysis.
Limitations of the current study included a selection bias with a tendency to select patients with more progressive disease for DBS surgery. Additionally, a potential selection bias may have occurred with the exclusion of a large proportion of the initial cohort. Twenty-four patients were excluded due to limited follow-up (only four with no follow-up). Eleven of these subjects continue to be followed by the University of Florida Centre for Movement Disorders and Neurorestoration, but their surgery was too recent Figure 3 Change in tremor at 36 months. Subjects with DBS and symptom improvement demonstrate a 22% improvement (i.e. 22% reduction in tremor rating scale motor score) while the seven subjects with DBS that demonstrated tremor worsening deteriorated by 34% (34% increase in tremor rating scale motor score). The control subjects demonstrated a 32% worsening of tremor (32% increase in tremor rating scale score).
to be included in the analysed cohort, which focused on long term follow-up to uncover the desired outcomes. It is possible, but unlikely that those lost to follow-up may represent a slightly better controlled disease state than was captured in the cohort we utilized. Further, the difficulty in making a definitive and correct diagnosis of essential tremor without post-mortem examination may also confound the results of the current study. The retrospective nature of the study is also a significant limitation that prevented the inclusion of all the pertinent information and factors that may have influenced disease progression. Effects of unilateral versus bilateral DBS may also have confounded the results, even though unilateral and bilateral patients were similar in the baseline analysis, all outcome measures were analysed separately for these two groups. Tremor rating scale assessments were not performed by the same examiner at each follow-up appointment, which may confound the results; but with appropriate training, the FahnTolosa-Marin tremor rating scale has been demonstrated to maintain good interrater reliability (Stacey et al., 2007) . Inconsistent follow-up may have also introduced some unintentional bias. While we demonstrated similarity between excluded and included subjects, excluding a large proportion can introduce bias, especially with a small sample size. The current study may have also been limited by the mild severity of the control arm. Controls were matched only by age due to the relatively small number of controls with sufficient follow-up to meet inclusion criteria. Disease duration and baseline tremor severity differed between the two arms of the cohort and it would have been more ideal to have been able to match all of these factors. Finally, medications were also not controlled for in either the surgical or the non-surgical group.
Despite the limitations, this study offers important long-term follow-up data in support of disease progression following DBS surgery. The findings suggest that DBS tolerance may be over-reported in the literature, and that practitioners should be careful when reporting tolerance as it must be separated from the more common manifestation of disease progression. The tolerance versus disease progression work-up should include examining the trend in off stimulation scores, accounting for image based lead locations, and also for checking thresholds for clinical benefits and side effects during programming sessions.
